Henry Schein Company Profile (NASDAQ:HSIC)

About Henry Schein (NASDAQ:HSIC)

Henry Schein logoHenry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The technology and value-added services segment provides software, technology and other value-added services to healthcare practitioners. Its technology group offerings include practice management software systems for dental and medical practitioners and animal health clinics. The Company provides its services to dental practitioners and laboratories, animal health clinics and physician practices, as well as government and institutional healthcare clinics.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Equipment Wholesale
  • Sub-Industry: Health Care Distributors
  • Symbol: NASDAQ:HSIC
  • CUSIP: 80640710
  • Web: www.henryschein.com
  • Market Cap: $13.37 billion
  • Outstanding Shares: 158,111,000
Average Prices:
  • 50 Day Moving Avg: $82.53
  • 200 Day Moving Avg: $87.26
  • 52 Week Range: $73.11 - $93.50
  • Trailing P/E Ratio: 24.28
  • Foreward P/E Ratio: 21.08
  • P/E Growth: 2.24
Sales & Book Value:
  • Annual Revenue: $11.97 billion
  • Price / Sales: 1.12
  • Book Value: $18.48 per share
  • Price / Book: 4.57
  • EBITDA: $1.02 billion
  • Net Margins: 4.74%
  • Return on Equity: 19.10%
  • Return on Assets: 8.34%
  • Debt-to-Equity Ratio: 0.28%
  • Current Ratio: 1.55%
  • Quick Ratio: 0.85%
  • Average Volume: 912,123 shs.
  • Beta: 1.08
  • Short Ratio: 5.11

Frequently Asked Questions for Henry Schein (NASDAQ:HSIC)

What is Henry Schein's stock symbol?

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

When did Henry Schein's stock split? How did Henry Schein's stock split work?

Shares of Henry Schein split on the morning of Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly created shares were distributed to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of Henry Schein stock prior to the split would have 200 shares after the split.

How will Henry Schein's stock buyback program work?

Henry Schein announced that its board has initiated a stock repurchase program on Tuesday, September 19th 2017, which allows the company to buyback $400,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to purchase up to 6.3% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's board of directors believes its stock is undervalued.

How were Henry Schein's earnings last quarter?

Henry Schein, Inc. (NASDAQ:HSIC) issued its quarterly earnings data on Tuesday, August, 8th. The company reported $0.88 EPS for the quarter, topping analysts' consensus estimates of $0.87 by $0.01. The company had revenue of $3.06 billion for the quarter, compared to analysts' expectations of $3.05 billion. Henry Schein had a return on equity of 19.10% and a net margin of 4.74%. The business's revenue was up 6.4% compared to the same quarter last year. During the same period last year, the company posted $0.82 earnings per share. View Henry Schein's Earnings History.

When will Henry Schein make its next earnings announcement?

Henry Schein is scheduled to release their next quarterly earnings announcement on Tuesday, October, 31st 2017. View Earnings Estimates for Henry Schein.

What guidance has Henry Schein issued on next quarter's earnings?

Henry Schein updated its FY17 earnings guidance on Tuesday, August, 8th. The company provided earnings per share guidance of $7.17-7.30 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.29.

Where is Henry Schein's stock going? Where will Henry Schein's stock price be in 2017?

15 brokers have issued twelve-month price objectives for Henry Schein's shares. Their predictions range from $81.50 to $109.00. On average, they expect Henry Schein's stock price to reach $92.86 in the next twelve months. View Analyst Ratings for Henry Schein.

What are analysts saying about Henry Schein stock?

Here are some recent quotes from research analysts about Henry Schein stock:

  • 1. According to Zacks Investment Research, "Henry Schein exited second-quarter 2017 on a solid note with earnings and sales beating the Zacks Consensus Estimate. Apart from balanced growth across all its operating segments, Henry Schein's share gains in both the U.S. and overseas markets raise optimism. We are also positive about the company opening a National Distribution Service Center to strengthen its presence in central Ohio. On the flip side, over the last three months, the company has underperformed the broader industry. Also, despite the better-than-expected earnings, we are disappointed with the company’s unchanged EPS guidance for 2017. Meanwhile, Henry Schein’s venture in digital dentistry through DENTSPLY SIRONA deal may intensify its already weak operating margin scenario on escalating education and training expenses. Also, foreign currency fluctuations continued to mar the company’s financials." (8/9/2017)
  • 2. Evercore ISI analysts commented, "HSIC continues to deliver consistent HSD to LDD EPS growth despite an operating environment that has been somewhat mixed, albeit North American Dental continues to show signs of recovery. With the acquisition engine still churning and an elevated level of buybacks, management has been able to deliver the type of TSR expected and thus the valuation remains notably elevated on an absolute basis (less so on a relative basis). While we also value consistency and predictability, we acknowledge we missed the November entry point (fears of US slowdown) and thus at current levels see risk / reward as more fully balanced (particularly with extra week headwind in 2017 + unfavorable Fx environment). Given this dynamic we reiterate our Hold rating and argue shares are now accurately pricing in the current operating environment. Thus we await another period of uncertainty prior to revisiting our long-term constructive view on shares." (2/21/2017)

Are investors shorting Henry Schein?

Henry Schein saw a increase in short interest during the month of September. As of September 29th, there was short interest totalling 8,187,143 shares, an increase of 47.2% from the September 15th total of 5,562,584 shares. Based on an average daily trading volume, of 1,754,214 shares, the days-to-cover ratio is presently 4.7 days. Approximately 5.3% of the company's shares are sold short.

Who are some of Henry Schein's key competitors?

Who are Henry Schein's key executives?

Henry Schein's management team includes the folowing people:

  • Stanley M. Bergman, Chairman of the Board, Chief Executive Officer
  • James P. Breslawski CPA, President, Director; Chief Executive Officer of Henry Schein Global Dental Group
  • Steven Paladino CPA, Chief Financial Officer, Executive Vice President, Director
  • Peter McCarthy, President of Global Animal Health Group
  • David C. McKinley, President of Corporate Commercial Development Group, Chief Commercial Officer
  • Bob Minowitz, President, International Dental Group, EMEA Region
  • Bridget A. Ross, President of Global Medical Group
  • Gerald A. Benjamin, Chief Administrative Officer, Executive Vice President, Director
  • Mark E. Mlotek, Chief Strategic Officer, Executive Vice President, Director
  • Karen N. Prange, Executive Vice President; Chief Executive Officer of Global Animal Health, Medical and Dental Surgical Group

Who owns Henry Schein stock?

Henry Schein's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Fisher Asset Management LLC (0.53%), PGGM Investments (0.23%), Mountain Pacific Investment Advisers Inc. ID (0.17%), Neville Rodie & Shaw Inc. (0.08%), Shell Asset Management Co. (0.07%) and Montrusco Bolton Investments Inc. (0.07%). Company insiders that own Henry Schein stock include Barry J Alperin, David Mckinley, Donald J Kabat, Gerald A Benjamin, James A Harding, Kurt P Kuehn, Lonnie Shoff, Lorelei Mcglynn, Louis W Sullivan, Mark E Mlotek, Michael Racioppi, Michael S Ettinger, Norman S Matthews, Paul Brons, Paul Rose, Peter M Mccarthy, Philip A Laskawy, Robert Minowitz, Stanley Komaroff, Stanley M Bergman and Steven Paladino. View Institutional Ownership Trends for Henry Schein.

Who bought Henry Schein stock? Who is buying Henry Schein stock?

Henry Schein's stock was bought by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, PGGM Investments, Mountain Pacific Investment Advisers Inc. ID, Shell Asset Management Co., Neville Rodie & Shaw Inc., Montrusco Bolton Investments Inc., Pensionfund DSM Netherlands and Quantitative Systematic Strategies LLC. View Insider Buying and Selling for Henry Schein.

How do I buy Henry Schein stock?

Shares of Henry Schein can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Henry Schein's stock price today?

One share of Henry Schein stock can currently be purchased for approximately $84.53.

MarketBeat Community Rating for Henry Schein (NASDAQ HSIC)
Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  145 (Vote Outperform)
Underperform Votes:  300 (Vote Underperform)
Total Votes:  445
MarketBeat's community ratings are surveys of what our community members think about Henry Schein and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Henry Schein (NASDAQ:HSIC) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 10 Hold Ratings, 5 Buy Ratings
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $92.86 (9.85% upside)
Consensus Price Target History for Henry Schein (NASDAQ:HSIC)
Price Target History for Henry Schein (NASDAQ:HSIC)
Analysts' Ratings History for Henry Schein (NASDAQ:HSIC)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/19/2017Robert W. BairdSet Price TargetBuy$95.00N/AView Rating Details
10/19/2017Stifel NicolausReiterated RatingHold$89.00N/AView Rating Details
9/28/2017Jefferies Group LLCReiterated RatingHold$88.50LowView Rating Details
9/21/2017Morgan StanleyInitiated CoverageEqual -> Equal Weight$88.00LowView Rating Details
9/19/2017Royal Bank Of CanadaInitiated CoverageSector Perform -> Sector Perform$91.00HighView Rating Details
9/15/2017Piper Jaffray CompaniesUpgradeNeutral -> OverweightLowView Rating Details
8/29/2017Credit Suisse GroupReiterated RatingHold$87.50LowView Rating Details
8/7/2017Northcoast ResearchUpgradeNeutral -> Buy$109.00HighView Rating Details
5/10/2017Barrington ResearchBoost Price TargetOutperform -> Outperform$98.00 -> $99.00LowView Rating Details
4/11/2017Craig HallumInitiated CoverageHoldLowView Rating Details
3/15/2017Deutsche Bank AGInitiated CoverageHold -> Hold$87.00LowView Rating Details
2/22/2017Leerink SwannSet Price TargetHold$91.50N/AView Rating Details
2/21/2017Evercore ISIBoost Price TargetHold$80.00 -> $89.00N/AView Rating Details
1/10/2017GabelliUpgradeHold -> Buy$104.00N/AView Rating Details
11/3/2016J P Morgan Chase & CoReiterated RatingHold$81.50N/AView Rating Details
10/11/2016Goldman Sachs Group, Inc. (The)UpgradeNeutral -> Buy$92.50N/AView Rating Details
9/12/2016Bank of America CorporationInitiated CoverageBuy$92.50N/AView Rating Details
(Data available from 10/20/2015 forward)


Earnings History for Henry Schein (NASDAQ:HSIC)
Earnings by Quarter for Henry Schein (NASDAQ:HSIC)
Earnings History by Quarter for Henry Schein (NASDAQ HSIC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/31/2017$0.90N/AView Earnings Details
8/8/2017Q2 17$0.87$0.88$3.05 billion$3.06 billionViewListenView Earnings Details
5/9/2017Q1 17$0.83$0.88$2.83 billion$2.92 billionViewListenView Earnings Details
2/21/2017Q416$0.93$0.94$3.08 billion$3.12 billionViewListenView Earnings Details
11/2/2016Q316$0.83$0.84$2.88 billion$2.87 billionViewN/AView Earnings Details
8/4/2016Q216$0.82$0.82$2.85 billion$2.87 billionViewN/AView Earnings Details
5/3/2016Q116$0.70$0.71$2.66 billion$2.70 billionViewListenView Earnings Details
2/10/2016Q415$0.83$0.84$2.82 billion$2.90 billionViewListenView Earnings Details
11/4/2015Q315$0.74$0.78$2.70 billion$2.70 billionViewListenView Earnings Details
7/29/2015Q215$0.73$0.73$2.68 billion$2.60 billionViewListenView Earnings Details
5/4/2015Q1$0.64$0.64$2.54 billion$25.00 billionViewListenView Earnings Details
2/11/2015Q414$0.76$0.78$2.72 billion$2.70 billionViewListenView Earnings Details
11/6/2014Q314$0.66$0.67$2.55 billion$2.62 billionViewListenView Earnings Details
8/4/2014Q214$0.67$0.68$2.56 billion$2.60 billionViewListenView Earnings Details
5/6/2014Q1$0.57$0.59$2.43 billion$2.40 billionViewListenView Earnings Details
2/11/2014Q413$0.70$0.72$2.53 billion$2.50 billionViewListenView Earnings Details
11/5/2013Q313$0.61$0.61$2.37 billion$2.30 billionViewListenView Earnings Details
8/6/2013Q2 2013$0.62$0.62$2.39 billion$2.40 billionViewListenView Earnings Details
5/7/2013Q1 2013$0.54$0.53$2.25 billion$2.30 billionViewListenView Earnings Details
2/13/2013Q4 2012$0.61$0.63$2.40 billion$2.40 billionViewListenView Earnings Details
11/7/2012Q312$0.54$0.54$2.24 billion$2.23 billionViewN/AView Earnings Details
8/2/2012$0.55$0.56ViewN/AView Earnings Details
5/8/2012$0.46$0.49ViewN/AView Earnings Details
2/15/2012$0.56$0.58ViewN/AView Earnings Details
11/1/2011$0.50$0.50ViewN/AView Earnings Details
8/2/2011$0.50$0.51ViewN/AView Earnings Details
5/3/2011$0.40$0.41ViewN/AView Earnings Details
2/22/2011$0.48$0.50ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Henry Schein (NASDAQ:HSIC)
2017 EPS Consensus Estimate: $6.98
2018 EPS Consensus Estimate: $7.05
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20175$1.60$1.67$1.64
Q2 20175$1.71$1.77$1.74
Q3 20175$0.92$1.81$1.61
Q4 20175$1.97$1.99$1.98
Q1 20183$1.00$1.90$1.59
Q2 20183$0.99$2.02$1.65
Q3 20183$1.98$2.02$1.99
Q4 20183$1.08$2.22$1.82
(Data provided by Zacks Investment Research)


Dividend History for Henry Schein (NASDAQ:HSIC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Henry Schein (NASDAQ:HSIC)
Insider Ownership Percentage: 1.19%
Institutional Ownership Percentage: 44.74%
Insider Trades by Quarter for Henry Schein (NASDAQ:HSIC)
Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)
Insider Trades by Quarter for Henry Schein (NASDAQ:HSIC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/6/2017Paul RoseSVPSell2,126$172.51$366,756.26View SEC Filing  
5/11/2017Gerald A BenjaminEVPSell12,578$175.10$2,202,407.80View SEC Filing  
3/23/2017Lorelei McglynnSVPSell9,300$171.76$1,597,368.00View SEC Filing  
3/20/2017Michael RacioppiSVPSell9,969$171.69$1,711,577.61View SEC Filing  
3/17/2017Mark E MlotekEVPSell5,559$170.98$950,477.82View SEC Filing  
3/8/2017James A HardingSVPSell10,552$171.60$1,810,723.20View SEC Filing  
3/8/2017Philip A LaskawyDirectorSell1,103$171.51$189,175.53View SEC Filing  
3/2/2017Michael S EttingerSVPSell6,960$171.09$1,190,786.40View SEC Filing  
2/27/2017Donald J KabatDirectorSell4,334$173.62$752,469.08View SEC Filing  
2/22/2017Paul RoseSVPSell6,821$173.24$1,181,670.04View SEC Filing  
2/22/2017Steven PaladinoCFOSell13,072$173.40$2,266,684.80View SEC Filing  
12/12/2016Kurt P KuehnDirectorBuy1,000$151.41$151,410.00View SEC Filing  
11/3/2016Mark E MlotekEVPSell2,417$155.19$375,094.23View SEC Filing  
8/29/2016Paul BronsDirectorSell3,381$164.03$554,585.43View SEC Filing  
6/2/2016Gerald A BenjaminEVPSell9,991$175.08$1,749,224.28View SEC Filing  
5/16/2016James A HardingSVPSell10,302$172.60$1,778,125.20View SEC Filing  
5/12/2016Peter M MccarthyInsiderSell1,158$171.75$198,886.50View SEC Filing  
3/15/2016Lonnie ShoffCEOSell3,028$168.29$509,582.12View SEC Filing  
3/14/2016David MckinleyInsiderSell3,339$167.92$560,684.88View SEC Filing  
3/14/2016Norman S MatthewsDirectorSell5,335$167.75$894,946.25View SEC Filing  
3/10/2016Donald J KabatDirectorSell1,218$168.38$205,086.84View SEC Filing  
3/7/2016Barry J AlperinDirectorSell1,635$167.36$273,633.60View SEC Filing  
3/7/2016Michael S EttingerSVPSell5,423$168.13$911,768.99View SEC Filing  
3/4/2016Philip A LaskawyDirectorSell1,317$166.88$219,780.96View SEC Filing  
3/2/2016Louis W SullivanDirectorSell11,735$168.59$1,978,403.65View SEC Filing  
3/2/2016Mark E MlotekEVPSell4,982$167.93$836,627.26View SEC Filing  
2/26/2016Barry J AlperinDirectorSell7,540$167.96$1,266,418.40View SEC Filing  
2/24/2016Robert MinowitzInsiderSell9,648$165.48$1,596,551.04View SEC Filing  
2/22/2016Michael RacioppiSVPSell21,567$166.74$3,596,081.58View SEC Filing  
2/17/2016Stanley KomaroffInsiderSell8,000$163.53$1,308,240.00View SEC Filing  
2/16/2016Norman S MatthewsDirectorSell4,230$160.05$677,011.50View SEC Filing  
2/12/2016Steven PaladinoCFOSell11,727$157.21$1,843,601.67View SEC Filing  
2/11/2016Donald J. KabatDirectorSell6,637$156.36$1,037,761.32View SEC Filing  
12/17/2015Michael RacioppiSVPSell9,901$155.92$1,543,763.92View SEC Filing  
12/10/2015Stanley M. BergmanCEOSell61,800$155.45$9,606,810.00View SEC Filing  
11/9/2015Paul RoseSVPSell3,638$151.92$552,684.96View SEC Filing  
11/5/2015Mark E. MlotekEVPSell2,952$155.00$457,560.00View SEC Filing  
11/5/2015Stanley KomaroffInsiderSell6,297$154.89$975,342.33View SEC Filing  
9/16/2015Philip A LaskawyDirectorSell4,000$136.20$544,800.00View SEC Filing  
5/6/2015Paul BronsDirectorSell3,801$136.70$519,596.70View SEC Filing  
3/19/2015Michael S EttingerSVPSell4,352$139.75$608,192.00View SEC Filing  
3/18/2015James P BreslawskiCEOSell12,811$139.45$1,786,493.95View SEC Filing  
3/17/2015Leonard A DavidSVPSell3,935$140.00$550,900.00View SEC Filing  
3/16/2015Paul RoseSVPSell3,264$140.13$457,384.32View SEC Filing  
3/13/2015Norman S MatthewsDirectorSell9,200$136.07$1,251,844.00View SEC Filing  
3/11/2015Philip A LaskawyDirectorSell2,669$136.60$364,585.40View SEC Filing  
3/10/2015Donald J KabatDirectorSell2,002$138.00$276,276.00View SEC Filing  
3/5/2015Barry J AlperinDirectorSell6,637$140.64$933,427.68View SEC Filing  
2/24/2015Stanley KomaroffInsiderSell8,000$141.69$1,133,520.00View SEC Filing  
2/12/2015Donald J KabatDirectorSell5,000$142.68$713,400.00View SEC Filing  
2/12/2015Gerald A BenjaminEVPSell22,116$142.71$3,156,174.36View SEC Filing  
2/12/2015Robert MinowitzInsiderSell11,254$142.63$1,605,158.02View SEC Filing  
12/18/2014Leonard A DavidSVPSell3,557$135.34$481,404.38View SEC Filing  
12/9/2014Stanley M BergmanCEOSell69,600$135.56$9,434,976.00View SEC Filing  
12/8/2014Stanley M BergmanCEOSell23,485$136.34$3,201,944.90View SEC Filing  
11/24/2014Stanley KomaroffInsiderSell13,757$133.06$1,830,506.42View SEC Filing  
11/7/2014Lorelei McglynnSVPSell15,746$129.03$2,031,706.38View SEC Filing  
11/7/2014Mark E MlotekEVPSell6,262$128.75$806,232.50View SEC Filing  
9/2/2014Philip A LaskawyDirectorSell15,438$119.40$1,843,297.20View SEC Filing  
8/29/2014Louis W SullivanDirectorSell17,262$119.99$2,071,267.38View SEC Filing  
6/9/2014Barry J AlperinDirectorSell7,500$120.39$902,925.00View SEC Filing  
6/2/2014Gerald A BenjaminEVPSell12,354$119.50$1,476,303.00View SEC Filing  
5/28/2014Norman S MatthewsDirectorSell6,637$118.68$787,679.16View SEC Filing  
5/19/2014Donald KabatDirectorSell5,000$116.30$581,500.00View SEC Filing  
5/15/2014Paul BronsDirectorSell5,363$113.77$610,148.51View SEC Filing  
3/19/2014Barry AlperinDirectorSell7,500$119.18$893,850.00View SEC Filing  
3/17/2014Lonnie ShoffCEOSell3,722$119.06$443,141.32View SEC Filing  
3/12/2014Michael EttingerSVPSell3,537$119.20$421,610.40View SEC Filing  
3/11/2014David MckinleyInsiderSell2,387$119.65$285,604.55View SEC Filing  
3/11/2014James BreslawskiCEOSell72,642$119.35$8,669,822.70View SEC Filing  
3/11/2014Paul RoseSVPSell3,783$119.72$452,900.76View SEC Filing  
3/10/2014Robert MinowitzInsiderSell11,553$119.98$1,386,128.94View SEC Filing  
3/4/2014Donald KabatDirectorSell5,000$119.15$595,750.00View SEC Filing  
2/28/2014Michael RacioppiSVPSell18,614$118.91$2,213,390.74View SEC Filing  
2/26/2014Stanley KomaroffInsiderSell18,000$119.36$2,148,480.00View SEC Filing  
2/25/2014Mark MlotekEVPSell20,333$119.16$2,422,880.28View SEC Filing  
2/20/2014Steven PaladinoCFOSell28,757$117.79$3,387,287.03View SEC Filing  
2/12/2014Philip LaskawyDirectorSell5,851$114.91$672,338.41View SEC Filing  
12/19/2013Mark MlotekEVPSell22,004$111.97$2,463,787.88View SEC Filing  
12/19/2013Michael RacioppiSVPSell29,257$111.97$3,275,906.29View SEC Filing  
12/17/2013Gerald BenjaminEVPSell41,664$111.66$4,652,202.24View SEC Filing  
12/17/2013James BreslawskiCEOSell57,754$111.91$6,463,250.14View SEC Filing  
12/16/2013Steven PaladinoCFOSell47,652$112.31$5,351,796.12View SEC Filing  
12/13/2013Stanley BergmanCEOSell78,000$111.90$8,728,200.00View SEC Filing  
12/6/2013Leonard DavidSVPSell13,968$113.14$1,580,339.52View SEC Filing  
11/26/2013Stanley KomaroffInsiderSell22,329$114.79$2,563,145.91View SEC Filing  
8/23/2013Philip LaskawyDirectorSell21,637$103.17$2,232,289.29View SEC Filing  
8/22/2013Norman MatthewsDirectorSell9,851$103.95$1,024,011.45View SEC Filing  
8/20/2013Louis SullivanDirectorSell15,000$103.91$1,558,650.00View SEC Filing  
8/12/2013Donald KabatDirectorSell2,500$106.25$265,625.00View SEC Filing  
6/18/2013Barry J AlperinDirectorSell7,500$97.74$733,050.00View SEC Filing  
5/8/2013James A HardingCTOSell12,000$92.64$1,111,680.00View SEC Filing  
3/8/2013Donald J KabatDirectorSell4,038$90.00$363,420.00View SEC Filing  
12/4/2012Donald J KabatDirectorSell15,000$80.04$1,200,600.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Henry Schein (NASDAQ:HSIC)
Latest Headlines for Henry Schein (NASDAQ:HSIC)
prnewswire.com logoHenry Schein To Showcase Leading Digital Solutions At The ... - PR Newswire (press release)
www.prnewswire.com - October 20 at 3:54 AM
finance.yahoo.com logoHenry Schein To Showcase Leading Digital Solutions At The American Dental Association Annual Meeting
finance.yahoo.com - October 19 at 10:50 PM
americanbankingnews.com logoHenry Schein, Inc. (HSIC) Receives Hold Rating from Stifel Nicolaus
www.americanbankingnews.com - October 19 at 11:44 AM
finance.yahoo.com logoThe Viscardi Center And Henry Schein, Inc. Announce "Project Accessible Oral Health"
finance.yahoo.com - October 19 at 2:48 AM
finance.yahoo.com logoHenry Schein Celebrates 25th Anniversary In Indianapolis
finance.yahoo.com - October 18 at 1:16 AM
americanbankingnews.com logoZacks: Analysts Anticipate Henry Schein, Inc. (HSIC) to Announce $0.90 Earnings Per Share
www.americanbankingnews.com - October 18 at 12:12 AM
nasdaq.com logoHenry Schein (HSIC) Inks Distribution Agreement with Terason - Nasdaq
www.nasdaq.com - October 17 at 8:14 PM
finance.yahoo.com logoHenry Schein Medical Announces Exclusive Distribution Agreement With Terason® For Ultrasound Device
finance.yahoo.com - October 16 at 10:44 PM
nasdaq.com logoHenry Schein Closes Merritt Buyout, Expands in Animal Health - Nasdaq
www.nasdaq.com - October 14 at 7:06 PM
nasdaq.com logoHenry Schein Gains on Strategic Buyouts, Cost Concern a Woe - Nasdaq
www.nasdaq.com - October 14 at 7:06 PM
finance.yahoo.com logoHenry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Northern California Wildfires
finance.yahoo.com - October 13 at 12:08 AM
finance.yahoo.com logoHenry Schein Closes Merritt Buyout, Expands in Animal Health
finance.yahoo.com - October 13 at 12:08 AM
finance.yahoo.com logoHenry Schein Donates More Than $18,000 In Dental Supplies To The Growing Smiles Foundation
finance.yahoo.com - October 12 at 6:09 AM
americanbankingnews.com logoShort Interest in Henry Schein, Inc. (HSIC) Increases By 47.2%
www.americanbankingnews.com - October 12 at 1:14 AM
americanbankingnews.com logoHenry Schein, Inc. (HSIC) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - October 11 at 4:50 AM
finance.yahoo.com logoHenry Schein Completes Acquisition Of Merritt Veterinary Supplies
finance.yahoo.com - October 10 at 7:00 PM
nasdaq.com logoHenry Schein to Offer CAS' Fully-Automated Cognivue Device - Nasdaq
www.nasdaq.com - October 6 at 8:07 PM
finance.yahoo.com logoHenry Schein Cares Medal Deadline Extended to October 12 at Midnight PT; Submit Your Application Now
finance.yahoo.com - October 5 at 8:28 PM
prnewswire.com logoDenmark's Dr. Mogens Hansen Receives 2017 Henry Schein Cares International Veterinary Community Service Award - PR Newswire (press release)
www.prnewswire.com - October 4 at 3:31 PM
finance.yahoo.com logoHenry Schein Medical to Distribute Cognivue®, the First Automated Screening Device Cleared to Detect Early Signs of Dementia
finance.yahoo.com - October 4 at 3:31 PM
americanbankingnews.com logoQ3 2017 EPS Estimates for Henry Schein, Inc. (HSIC) Reduced by Analyst
www.americanbankingnews.com - October 4 at 7:46 AM
finance.yahoo.com logoHenry Schein Donates 4,000 Welcome Kits To Guests Staying At American Cancer Society Hope Lodge Facilities
finance.yahoo.com - October 3 at 9:51 AM
finance.yahoo.com logoCramer's lightning round: Johnson & Johnson has the best ...
finance.yahoo.com - October 2 at 1:31 PM
finance.yahoo.com logoDenmark's Dr. Mogens Hansen Receives 2017 Henry Schein Cares International Veterinary Community Service Award
finance.yahoo.com - October 2 at 1:31 PM
americanbankingnews.com logoHenry Schein's (HSIC) "Hold" Rating Reiterated at Jefferies Group LLC
www.americanbankingnews.com - September 28 at 7:34 PM
americanbankingnews.com logoHenry Schein, Inc. (HSIC) Research Coverage Started at Morgan Stanley
www.americanbankingnews.com - September 21 at 10:02 AM
bloomberg.com logoRecent HSIC News
www.bloomberg.com - September 20 at 8:17 PM
finance.yahoo.com logoHenry Schein Joins Texas Health Care Leaders To Convene Expert-Led Symposium On Practice Recovery In Wake Of Hurricanes
finance.yahoo.com - September 20 at 8:17 PM
streetinsider.com logoHenry Schein (HSIC) to Increase Share Buyback Plan by $400M
www.streetinsider.com - September 20 at 5:41 AM
americanbankingnews.com logoHenry Schein (HSIC) Board of Directors Announces Share Buyback Plan
www.americanbankingnews.com - September 19 at 11:04 AM
americanbankingnews.com logoHenry Schein, Inc. (HSIC) Coverage Initiated by Analysts at Royal Bank Of Canada
www.americanbankingnews.com - September 19 at 7:38 AM
nasdaq.com logoHenry Schein To Repurchase Up To $400 Mln Of Shares
www.nasdaq.com - September 18 at 7:08 PM
finance.yahoo.com logoHenry Schein Announces $400 Million Increase To Share Repurchase Plan
finance.yahoo.com - September 18 at 7:08 PM
finance.yahoo.com logoHenry Schein announces share buyback of up to $400 mln
finance.yahoo.com - September 18 at 7:08 PM
benzinga.com logoLooking For Amazon-Proof Stocks? Try Henry Schein - Benzinga
www.benzinga.com - September 17 at 11:45 PM
americanbankingnews.com logoHenry Schein, Inc. (HSIC) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - September 16 at 4:42 AM
finance.yahoo.com logoLooking For Amazon-Proof Stocks? Try Henry Schein
finance.yahoo.com - September 16 at 1:06 AM
americanbankingnews.com logoHenry Schein, Inc. (HSIC) Upgraded to Overweight by Piper Jaffray Companies
www.americanbankingnews.com - September 15 at 11:40 PM
americanbankingnews.com logoHenry Schein, Inc. (HSIC) Stock Rating Reaffirmed by UBS AG
www.americanbankingnews.com - September 15 at 5:34 PM
nasdaq.com logoThursday Sector Laggards: Services, Healthcare - Nasdaq
www.nasdaq.com - September 14 at 8:47 PM
prnewswire.com logoTechnical Insights on Medical Equipment Wholesale Stocks -- Henry Schein, Patterson, Owens & Minor, and PharMerica - PR Newswire (press release)
www.prnewswire.com - September 14 at 8:47 PM
finance.yahoo.com logoETFs with exposure to Henry Schein, Inc. : September 14, 2017
finance.yahoo.com - September 14 at 8:47 PM
nasdaq.com logoMarket Close Report: Historical high reached as NASDAQ Composite Index closes at 6460.19. - Nasdaq
www.nasdaq.com - September 14 at 6:10 AM
finance.yahoo.com logoHenry Schein, Inc. breached its 50 day moving average in a Bullish Manner : HSIC-US : September 12, 2017
finance.yahoo.com - September 12 at 11:50 PM
americanbankingnews.com logoHenry Schein, Inc. (HSIC) Expected to Post Quarterly Sales of $3.05 Billion
www.americanbankingnews.com - September 12 at 6:08 AM
barrons.com logoHealth-Care Stocks Poised for More Gains - Barron's
www.barrons.com - September 11 at 8:04 PM
finance.yahoo.com logoHenry Schein MicroMD Software Gets ONC-Health IT Certificate
finance.yahoo.com - September 11 at 8:04 PM
americanbankingnews.com logo$1.79 Earnings Per Share Expected for Henry Schein, Inc. (HSIC) This Quarter
www.americanbankingnews.com - September 10 at 10:22 AM
finance.yahoo.com logoHenry Schein MicroMD EMR® Earns ONC-Health IT Certification From Drummond Group LLC
finance.yahoo.com - September 8 at 8:08 PM
americanbankingnews.com logoHenry Schein, Inc. (HSIC) SVP Paul Rose Sells 2,126 Shares
www.americanbankingnews.com - September 7 at 7:42 PM



Henry Schein (HSIC) Chart for Friday, October, 20, 2017

This page was last updated on 10/20/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.